The potential health benefits of morning coffee may extend far beyond its energizing effects, according to a groundbreaking study that examines the beverage's impact on liver health.
Published in a prominent medical journal, the research draws on data from a massive population of over 354,000 participants, who were tracked over an average period of 13 years.
Those who consumed one to two cups of coffee daily were found to have a significantly lower risk of developing cirrhosis and liver-related mortality compared to non-coffee drinkers, with a 20% lower risk of cirrhosis and a 31% lower risk of liver-related death.
As consumption levels increased, the protective effects became even more pronounced, with individuals who drank five or more cups of coffee per day experiencing a 32% reduction in cirrhosis risk, a 42% lower risk of liver-related death, and a 47% lower risk of developing primary liver cancer.
The study's findings suggest that the liver-protective benefits of coffee may be driven by naturally occurring compounds not related to caffeine, as both caffeinated and decaffeinated coffee showed similar benefits.
However, the researchers noted that adding sugar or artificial sweeteners to coffee may slightly weaken its beneficial effects, particularly concerning markers of liver inflammation.
While the study's findings are promising, the authors emphasized that coffee consumption should be viewed as a complementary measure to standard preventative health practices, rather than a replacement for them.
The research also highlighted the limitations of the study, which relied on self-reported dietary questionnaires and may be susceptible to changes in participants' coffee-drinking habits over time.
As such, the study's results should be interpreted with caution, and further research is needed to fully understand the relationship between coffee consumption and liver health.
